期刊文献+

费城染色体样急性淋巴细胞白血病基因改变及治疗研究进展 被引量:3

Research progress of genomic alterations and treatment of Ph-like acute lymphoblastic leukemia
原文传递
导出
摘要 费城染色体样急性淋巴细胞白血病(Ph—likeALL)涉及与其高危特点和预后不良相关的多种基因组改变,如IKZF1、CRLF2、JAK1/2、EBF1-PDGFRB、ATF7IP、EPOR、SH283等。JAK/STAT途径和P13K/mTOR途径已被证实很可能是某些Ph.1ikeALL的相关靶点,文章重点综述以上基因组改变及治疗进展。 Ph-like acute lymphoblastic leukemia (Ph-like ALL) involves various genomic alterations associated with high risk factors and poor clinical outcome, such as IKZF1, CRLF2, JAK1/2, EBF1-PDGFRB, ATF7IP, EPOR, SH2B3. JAK/STAT pathway and PI3K/mTOR pathway are likely to be the targets of Ph-like ALL. Here,the above genomic alterations and treatment progress are reviewed.
出处 《白血病.淋巴瘤》 CAS 2015年第9期573-576,共4页 Journal of Leukemia & Lymphoma
关键词 费城染色体样急性淋巴细胞白血病 基因 治疗 预后 Ph-like acute lymphoblastic leukemia Genome Therapy Prognosis
  • 相关文献

参考文献32

  • 1Mullighan CG,Su X,Zhang J,et al.Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia[J].N Engl J Med,2009,360(5):470-480.
  • 2den Boer ML,van Slegtenhorst M,De Menezes RX,et al.A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome:a genome-wide classification study[J].Lancet Oncol,2009,10(2):125-134.
  • 3Roberts KG,Morin RD,Zhang J,et al.Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia[J].Cancer Cell,2012,22(2):153-166.
  • 4李玉龙,翟亚萍,程薇,刘禄社,张茵.伴有Ph样染色体的急性白血病二例并文献复习[J].白血病.淋巴瘤,2011,20(12):751-753. 被引量:1
  • 5Loh ML,Zhang J,Harvey RC,et al.Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia:a report from the Children's Oncology Group TARGET Project[J].Blood,2013,121(3):485-488.
  • 6Harrison CJ.Genomic analysis drives tailored therapy in poor risk childhood leukemia[J].Cancer Cell,2012,22(2):139-140.
  • 7Russell LJ,Capasso M,Vater I,et al.Deregulated expression of cytokine receptor gene,CRLF2,is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia[J].Blood,2009,114(3):2688-2698.
  • 8Harvey RC,Mullighan CG,Chen IM,et al.Rearrangement of CRLF2 is associated with mutation of JAK kinases,alteration of IKZF1,Hispanic/Latino ethnicity,and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia[J].Blood,2010,115(26):5312-5321.
  • 9Mullighan CG,Zhang J,Harvey RC,et al.JAK mutations in high-risk childhood acute lymphoblastic leukemia[J].Proc Natl Acad Sci U S A,2009,106(23):9414-9418.
  • 10Yoda A,Yoda Y,Chiaretti S,et al.Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia[J].Proc Natl Acad Sci U S A,2010,107(1):252-257.

二级参考文献15

  • 1Graze P, Sparkes R, Como R, et al. Hematopoietic engraftment following transplantation of bone marrow ceils carrying a Philadelphia (Ph')-like chromosome. Am J Hematol, 1977, 3: 137-142.
  • 2Ohyashiki JH, Ohyashiki K, Fujieda H, et al. Myelodysplastic syndrome with Philadelphia-like chromosome without bcr rearrangement. Cancer Genet Cytogenet, 1988, 35: 151-158.
  • 3Hamada K, Takahashi I, Saika T, et al.Unclassified chronic myeloproliferative disorder (Ph negative/bcr rearrangement negative CML) with late appearing Philadelphia like chromosome. Rinsho Ketsueki, 1996, 37: 221-227.
  • 4Fossa A, Siebert R, Kasper C, et al. BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia. Br J Haematol, 1996, 93: 403-405.
  • 5Hiddemann W, Jabns-Streubel G, Verbeek W, et al. Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities. Leuk Res, 1998, 22 Suppll: S23-26.
  • 6Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol, 2008, 87: 515-526.
  • 7Mrozek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol, 2008, 35: 365-377.
  • 8Dutcher JP, Wiernik PH. Accelerated and blastic phase of chronic myeloid leukemia.Curr Treat Options Oncol, 2000, 1:51-69.
  • 9Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am, 2009, 23: 655-674.
  • 10Albano F, Anelli L, Zagaria A, et al. Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t (9;22) or additional chromosomal rearrangements. Mol Cancer, 2010, 9: 120.

同被引文献32

  • 1Ming Jia,Zhu-Jun Wang,Hai-Zhao Zhao,He-Ping Shen,Yu-Ping Cheng,Ze-Bin Luo,Yong-Min Tang.Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia:a meta-analysis[J].World Journal of Pediatrics,2015(2):126-133. 被引量:2
  • 2Vardiman JW, World Health neoplasms and Blood, 2009, Thiele J, Arber DA, et al. The 2008 revision of the Organization (WHO) classification of myeloid acute leukemia: rationale and important changes [J]. 114 (5): 937-951.
  • 3Drexler HG, Macleod RA. History of leukemia-lymphoma cell lines [J]. Hum Cell, 2010, 23 (3): 75-82.
  • 4Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents [J]. Nat Rev Cancer, 2010, 10(4): 241-253.
  • 5Rosenfeld C, Goutner A, Choquet C, et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line [J]. Nature, 1977, 267(5614) : 841-843.
  • 6Matsuo Y, Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines [ J ]. Leuk Res, 1998, 22 (7) : 567-579.
  • 7Zhang LQ, Downie PA, Goodell WR, et al. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia [J]. Leukemia, 1993, 7( 11 ) : 1865-1874.
  • 8Faded S, Albitar M. Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia[ J ]. Hematol Oncol Clin North Am, 2000, 14(6): 1267-1288.
  • 9Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762) [J]. Blood, 1992, 80 (12) : 2983-2990.
  • 10Gleissner B, Gtikbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Muhicenter Trial Group and confirmed polymerase chain reaction analysis[J]. Blood, 2002, 99(5): 1536-1543.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部